Birth defects and epilepsy medication

References

• Fairgrieve SD, Jackson M, Jonas P et al. Population based, prospective study of the care of women with epilepsy in pregnancy. Br. Med. J.321(7262), 674–675 (2000).
   PubMed Web of Science ®Google Scholar
• Epilepsy Guidelines Group. Primary care guidelines for the management of females with epilepsy. Royal Society of Medicine Publishers Ltd, UK (2004).
   Google Scholar
• Tomson T, Perucca E, Battino D. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Epilepsia45, 1171–1175 (2004).
   PubMed Web of Science ®Google Scholar
• Stumpf DA, Frost M. Seizures, anticonvulsants, and pregnancy. Am. J. Dis. Child132(8), 746–748 (1978).
   PubMedGoogle Scholar
• Teramo K, Hiilesmaa V, Bardy A, Saarikoski S. Fetal heart rate during a maternal grand mal epileptic seizure. J. Perinatal Med.7(1), 3–6 (1979).
   PubMed Web of Science ®Google Scholar
• Minkoff H, Schaffer RM, Delke I, Grunebaum AN. Diagnosis of intracranial hemorrhage in utero after a maternal seizure. Obstet. Gynecol.65(3 Suppl.), S22–S24 (1985).
   PubMed Web of Science ®Google Scholar
• Zahn CA, Morrell MJ, Collins SD, Labiner DM, Yerby MS. Management issues for women with epilepsy: a review of the literature. Neurology51(4), 949–956 (1998).
   PubMed Web of Science ®Google Scholar
• Teramo K, Hiilesmaa V. Pregnancy and fetal complications in epileptic pregnancies: review of the literature. Janz D, Bossi L, Dam M (Eds). In: Epilepsy Pregnancy and the Child. Raven Press, NY, USA 53–59 (1982).
   Google Scholar
• EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology66, 354–360 (2006).
   Google Scholar
• Nei M, Daly S, Liporace J. A maternal complex partial seizure in labor can affect fetal heart rate. Neurology51(3), 904–906 (1998).
   PubMed Web of Science ®Google Scholar
• Sahoo S, Klein P. Maternal complex partial seizure associated with fetal distress. Arch. Neurol.62,1304–1305 (2005).
   PubMedGoogle Scholar
• Lindhout D, Meinardi H, Meijer JW, Nau H. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology42(4 Suppl. 5), 94–110 (1992).
   PubMedGoogle Scholar
• Holmes LB, Harvey EA, Coull BA et al. The teratogenicity of anticonvulsant drugs. N. Engl. J. Med.344(15), 1132–1138 (2001).
   PubMed Web of Science ®Google Scholar
• Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology60, 575–579 (2003).
   PubMed Web of Science ®Google Scholar
• Canger R, Battino D, Canevini MP et al. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia40(9), 1231–1236 (1999).
   PubMed Web of Science ®Google Scholar
• Kaneko S, Battino D, Andermann Eet al. Congenital malformations due to antiepileptic drugs. Epilepsy Res.33(2–3), 145–158 (1999).
   PubMed Web of Science ®Google Scholar
• Kaneko S, Otani K, Fukushima Y et al. Teratogenicity of antiepileptic drugs: analysis of possible risk factors. Epilepsia29(4), 459–467 (1988).
   PubMed Web of Science ®Google Scholar
• Samren EB, Van Duijn CM, Christiaens GCML, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Annals Neurol.46(5), 739–746 (1999).
   PubMed Web of Science ®Google Scholar
• Fried S, Kozer E, Nulman I, Einarson TR, Koren G. Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf.27, 197–202 (2004).
   PubMed Web of Science ®Google Scholar
• Yerby MS. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology55(5 Suppl. 1), S21–S31 (2000).
   PubMed Web of Science ®Google Scholar
• Hvas CL, Henriksen TB, Ostergaard JR. Birth weight in offspring of women with epilepsy. Epidemiologic Reviews22(2), 275–282 (2000).
   PubMedGoogle Scholar
• Wide K, Winbladh B, Tomson T, Kallen B. Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years. Epilepsia41(7), 854–861 (2000).
   PubMed Web of Science ®Google Scholar
• Kalter H. Teratology in the 20th century: environmental causes of congenital malformations in humans and how they were established. Neurotoxicol. Teratol.25, 131–282 (2003).
   PubMed Web of Science ®Google Scholar
• Pennell PB. The importance of monotherapy in pregnancy. Neurology60, S31–S38 (2003).
   PubMed Web of Science ®Google Scholar
• Stokes T, Shaw EJ, Juarez-Garcia A, Camosso-Stefinovic J, Baker R. Clinical Guidelines and Evidence Review for the Epilepsies: diagnosis and management in adults and children in primary and secondary care. NICE Clinical Guideline no. CG20. Royal College of General Practitioners (2004).
   Google Scholar
• Samren EB, van Duijn CM, Koch S et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia38(9), 981–990 (1997).
   PubMed Web of Science ®Google Scholar
• Annegers JF, Hauser WA, Elveback LR, Anderson VE, Kurland LI. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Int. J. Epidemiol.7(3), 241–247 (1978).
   PubMed Web of Science ®Google Scholar
• Kallen B, Robert E, Mastroiacovo P, Martinez-Frias ML, Castilla EE, Cocchi G. Anticonvulsant drugs and malformations. Is there a drug specificity? Eur. J. Epidemiol.5(1), 31–36 (1989).
   Google Scholar
• Arpino C, Brescianini S, Robert E et al. Teratogenic effects of antiepileptic drugs: use of an international database on Malformations and Drug Exposure (MADRE). Epilepsia41(11), 1436–1443 (2000).
   PubMed Web of Science ®Google Scholar
• Wide K, Winbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr.93, 174–176 (2004).
   PubMed Web of Science ®Google Scholar
• Omtzigt JG, Los FJ, Grobbee DE et al. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology42(4 Suppl. 5), 119–125 (1992).
   PubMed Web of Science ®Google Scholar
• Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies. Neurology57(2), 321–324 (2001).
   PubMed Web of Science ®Google Scholar
• Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N. Engl. J. Med.343(22), 1608–1614 (2000).
   PubMed Web of Science ®Google Scholar
• Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am. J. Epidemiol.153(10), 961–968 (2001).
   PubMed Web of Science ®Google Scholar
• Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N. Engl. J. Med.324(10), 674–677 (1991).
   PubMed Web of Science ®Google Scholar
• Morrow JI, Russell A, Gutherie E, Parsons L, Robertson I, Waddell R. Malformation risks of anti-epileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatry77(2), 193–198 (2006).
   PubMed Web of Science ®Google Scholar
• Cunnington M,Tennis P. Lamotrigine and the risk of malformations in pregnancy. Neurology64, 955–960 (2005).
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E. EURAP: an international registry of antiepileptic drugs and pregnancy. Epilepsia45, 1463–1464 (2004).
   PubMed Web of Science ®Google Scholar
• Holmes LB, Wyszynski DF. North American antiepileptic drug pregnancy registry. Epilepsia45, 1465 (2004).
   PubMed Web of Science ®Google Scholar
• Vajda FJ, O'Brien TJ, Hitchcock A, Graham J, Cook M, Lander C. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J. Clin. Neurosci.11, 854–858 (2004).
   PubMed Web of Science ®Google Scholar
• Holmes LB, Wyszynski DF, Lieberman E. The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch. Neurol.61, 673–678 (2004).
   PubMed Web of Science ®Google Scholar
• Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology64, 961–965 (2005).
   PubMed Web of Science ®Google Scholar
• Artama M, Auvinen A, Raudaskoski T, Isojarvi I, Isojarvi J. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology64, 1874–1878 (2005).
   PubMed Web of Science ®Google Scholar
• Matalon S, Schechtman S, Goldzweig G, Ornoy A. The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod. Toxicol.16(1), 9–17 (2002).
   PubMed Web of Science ®Google Scholar
• Montouris G. Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr. Med. Res. Opin.21, 693–701 (2005).
   PubMed Web of Science ®Google Scholar
• Meischenguiser R, D’Giano CH, Ferraro SM. Oxcarbazepine in pregnancy: clinical experience in Argentina. Epilepsy Behav.5, 163–167 (2004).
   PubMed Web of Science ®Google Scholar
• Morrow JI, Craig JJ. Anti-epileptic drugs in pregnancy: current safety and other issues. Expert Opin. Pharmacother.4, 445–456 (2003).
   PubMed Web of Science ®Google Scholar
• Hoyme HE, Hauck L, Quinn D. Minor anomalies accompanying prenatal exposure to topiramate. Epilepsia56(1), 119A (1998).
   Google Scholar
• Yerby MS. Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation. Epilepsia44(Suppl. 3), 33–40 (2003).
   PubMed Web of Science ®Google Scholar
• Wilton LV, Shakir SA. Postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England. Epilepsia43(9), 983–992 (2002).
   PubMed Web of Science ®Google Scholar
• Montouris G. Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav.4, 310–317 (2003).
   PubMed Web of Science ®Google Scholar
• Genton P, Van Vleymen B. Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles. Epileptic Disord.2, 99–105 (2000).
   PubMed Web of Science ®Google Scholar
• ten Berg K, Samren EB, van Oppen AC, Engelsman M, Lindhout D. Levetiracetam use and pregnancy outcome. Reprod. Toxicol.20, 175–178 (2005).
   PubMed Web of Science ®Google Scholar
• Vajda FJ, Eadie MJ. Maternal valproate dosage and foetal malformations. Acta Neurol. Scand.112, 137–143 (2005).
   PubMed Web of Science ®Google Scholar
• Gaily E, Granstrom ML. Minor anomalies in children of mothers with epilepsy. Neurology42(4 Suppl. 5), 128–131 (1992).
   Google Scholar
• Adab N, Tudur-Smith C , Winterbottom J, Vinten J, Williamson P. Common antiepileptic drugs in pregnancy in women with epilepsy. Part 1 Neurodevelopmental outcomes. In: The Cochrane Library. Cochrane Review2 (2004).
   Google Scholar
• Dean JC, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. Long-term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J. Med. Genet.39, 251–259 (2002).
   PubMed Web of Science ®Google Scholar
• Gaily E, Kantola-Sorsa E, Granstrom ML. Specific cognitive dysfunction in children with epileptic mothers. Dev. Med. Child Neurol.32(5), 403–414 (1990).
   PubMed Web of Science ®Google Scholar
• Gaily E, Kantola-Sorsa E, Hiilesmaa V et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology62(1), 28–32 (2004).
   PubMed Web of Science ®Google Scholar
• Wide K, Winbladh B, Tomson T, Sars-Zimmer K, Berggren E. Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population-based study. Dev. Med. Child Neurol.42(2), 87–92 (2000).
   PubMed Web of Science ®Google Scholar
• Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J. The longer term outcome of children born to mothers with epilepsy. J. Neurol. Neurosurg. Psychiatry75, 1575–1583 (2004).
   PubMed Web of Science ®Google Scholar
• Ohtsuka Y, Silver K, Lopes-Cendes I et al. Effect of antiepileptic drugs on psychomotor development in offspring of epileptic mothers. Epilepsia40(Suppl. 2), 296 (1999).
   Google Scholar
• Gaily E, Kantola-Sorsa E, Hiilesmaa V, Isoaho M, Matila R, Kotila M. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology62, 228–232 (2004).
   PubMed Web of Science ®Google Scholar
• Eriksson K, Viinikainen K, Monkkonen A, Aikia M, Nieminen P, Heinonen S. Children exposed to valproate in utero-population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res.65, 189–200 (2005).
   PubMed Web of Science ®Google Scholar
• Dean JC, Moore SJ, Turnpenny PD. Developing diagnostic criteria for the fetal anticonvulsant syndromes. Seizure9, 233–234 (2000).
   PubMed Web of Science ®Google Scholar
• Gaily E, Granstrom ML, Hiilesmaa V, Bardy A. Minor anomalies in offspring of epileptic mothers. J. Pediatr.112(4), 520–529 (1988).
   PubMed Web of Science ®Google Scholar
• Duncan S, Mercho S, Lopes-Cendes I et al. Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality. Epilepsia42(6), 750–753 (2001).
   PubMed Web of Science ®Google Scholar
• Malm H, Kajantie E, Kivirikko S, Kaariainen H, Peippo M, Somer M. Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility. Neurology59, 630–633 (2002).
   PubMed Web of Science ®Google Scholar
• Dean JCS, Moore SJ, Osborne A, Howe J, Turnpenny PD. Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene. Clin. Genetics56(3), 216–220 (1999).
   PubMed Web of Science ®Google Scholar
• Buehler BA, Delimont D, van Waes M, Finnell RH. Prenatal prediction of risk of the fetal hydantoin syndrome N. Engl. J. Med.322(22), 1567–1572 (1990).
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Kaneko S, Otani K, Fukushima Y. Serum folic acid levels in epileptic mothers and their relationship to congenital malformations. Epilepsy Res.8(1), 75–78 (1991).
   Google Scholar
• Charles D, Ness AR, Campbell D, Davey Smith G, Hall MH. Taking folate in pregnancy and risk of maternal breast cancer. Br. Med. J.329, 1375–1376 (2004).
   PubMed Web of Science ®Google Scholar
• Oakley GP, Mandel JS. Folic acid fortification remains an urgent health priority. Br. Med. J.329, 1376 (2004).
   Google Scholar
• Pennell PB. Pregnancy in women who have epilepsy. Neurol. Clin.22, 799–820 (2004).
   PubMed Web of Science ®Google Scholar
• Delgado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology34, 285–294 (1984).
   PubMed Web of Science ®Google Scholar
• Nicolson A, Appleton RE, Chadwick DW, Smith DF. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J. Neurol. Neurosurg. Psychiatry75, 75–79 (2004).
   PubMed Web of Science ®Google Scholar
• Battino D, Binelli S, Caccamo ML et al. Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol. Scand.85(3), 204–207 (1992).
   PubMed Web of Science ®Google Scholar